Atherogenic index of plasma is related to arterial stiffness but not to blood pressure in normotensive and never-treated hypertensive subjects

References

• World health organisation. WHO | Cardiovascular diseases (CVDs). WHO. 2017. http://www.who.int/mediacentre/factsheets/fs317/en/.
   Google Scholar
• Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2011;123:e18–e209.
   PubMed Web of Science ®Google Scholar
• Cholesterol Treatment Trialists’ (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581–590.
   PubMed Web of Science ®Google Scholar
• Lamarche F, Agharazii M, Nadeau-Fredette A-C, et al. Central and brachial blood pressures, statins, and low-density lipoprotein cholesterol: a mediation analysis. Hypertension. 2018;71:415–421.
   PubMed Web of Science ®Google Scholar
• Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J. 2017;38:2478–2486.
   PubMed Web of Science ®Google Scholar
• Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–1389.
   PubMed Web of Science ®Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;63:2889–2934.
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG, Benn M, Schnohr P, et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298:299–308.
   PubMed Web of Science ®Google Scholar
• Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation. 2007;115:450–458.
   PubMed Web of Science ®Google Scholar
• Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213–219.
   PubMedGoogle Scholar
• Vlachopoulos C, Aznaouridis K, O'Rourke MF, et al. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31:1865–1871.
   PubMed Web of Science ®Google Scholar
• Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension. 2009;54:1328–1336.
   PubMed Web of Science ®Google Scholar
• Choudhary MK, Eräranta A, Tikkakoski AJ, et al. LDL cholesterol is associated with systemic vascular resistance and wave reflection in subjects naive to cardiovascular drugs. Blood Press. 2019;28:4–14.
   Web of Science ®Google Scholar
• Wang X, Ye P, Cao R, et al. Triglycerides are a predictive factor for arterial stiffness: a community-based 4.8-year prospective study. Lipids Health Dis. 2016;15:97.
   PubMed Web of Science ®Google Scholar
• Wang X, Du Y, Fan L, et al. Relationships between HDL-C, hs-CRP, with central arterial stiffness in apparently healthy people undergoing a general health examination. PLoS ONE. 2013;8:e81778.
   PubMed Web of Science ®Google Scholar
• Kawasoe S, Ide K, Usui T, et al. Association of serum triglycerides with arterial stiffness in subjects with low levels of low-density lipoprotein cholesterol. Circ J. 2018;82:3052–3057.
   Web of Science ®Google Scholar
• Wang F, Ye P, Luo L, et al. Association of serum lipids with arterial stiffness in a population-based study in Beijing. Eur J Clin Invest. 2011;41:929–936.
   PubMed Web of Science ®Google Scholar
• Dobiás˘ová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL). Clin Biochem. 2001;34:583–588.
   PubMed Web of Science ®Google Scholar
• Tan MH, Johns D, Glazer NB. Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clin Chem. 2004;50:1184–1188.
   PubMed Web of Science ®Google Scholar
• Dobiášová M. Atherogenic index of plasma [Log(triglycerides/HDL-cholesterol)]: theoretical and practical Implications. Clin Chem. 2004;50:1113–1115.
   PubMed Web of Science ®Google Scholar
• Dobiášová M, Frohlich J, Šedová M, et al. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J Lipid Res. 2011;52:566–571.
   PubMed Web of Science ®Google Scholar
• Frohlich J, Dobiášová M. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem. 2003;49:1873–1880.
   PubMed Web of Science ®Google Scholar
• Holmes DT, Frohlich J, Buhr KA. The concept of precision extended to the atherogenic index of plasma. Clin Biochem. 2008;41:631–635.
   PubMed Web of Science ®Google Scholar
• Cai G, Shi G, Xue S, et al. The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population. Medicine (Baltimore). 2017;96:e8058.
   PubMed Web of Science ®Google Scholar
• Wu T-T, Gao Y, Zheng Y-Y, et al. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis. 2018;17:197.
   PubMed Web of Science ®Google Scholar
• Cure E, Icli A, Uslu AU, et al. Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis: AIP associate with cIMT in AS. Clin Rheumatol. 2018;37:1273–1280.
   PubMed Web of Science ®Google Scholar
• Shen S, Lu Y, Qi H, et al. Association between ideal cardiovascular health and the atherogenic index of plasma. Medicine (Baltimore). 2016;95:e3866.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–3104.
   PubMed Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402–2410.
   PubMed Web of Science ®Google Scholar
• Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20–29.
   PubMed Web of Science ®Google Scholar
• Chen C-H, Nevo E, Fetics B, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation. 1997;95:1827–1836.
   PubMed Web of Science ®Google Scholar
• Wilenius M, Tikkakoski AJ, Tahvanainen AM, et al. Central wave reflection is associated with peripheral arterial resistance in addition to arterial stiffness in subjects without antihypertensive medication. BMC Cardiovasc Disord. 2016;16:131.
   PubMed Web of Science ®Google Scholar
• Kööbi T, Kaukinen S, Ahola T, et al. Non-invasive measurement of cardiac output: whole-body impedance cardiography in simultaneous comparison with thermodilution and direct oxygen fick methods. Intensive Care Med. 1997;23:1132–1137.
   PubMed Web of Science ®Google Scholar
• Koskela JK, Tahvanainen A, Haring A, et al. Association of resting heart rate with cardiovascular function: a cross-sectional study in 522 Finnish subjects. BMC Cardiovasc Disord. 2013;13:102.
   PubMed Web of Science ®Google Scholar
• Kööbi T, Kähönen M, Iivainen T, et al. Simultaneous non-invasive assessment of arterial stiffness and haemodynamics - a validation study. Clin Physiol Funct Imaging. 2003;23:31–36.
   PubMed Web of Science ®Google Scholar
• Tahvanainen A, Koskela J, Tikkakoski A, et al. Analysis of cardiovascular responses to passive head-up tilt using continuous pulse wave analysis and impedance cardiography. Scand J Clin Lab Invest. 2009;69:128–137.
   PubMed Web of Science ®Google Scholar
• Finnish Guidelines for the Current Care of Subjects with Alcohol Problem. 2015. http://www.kaypahoito.fi/web/kh/suositukset/suositus?id=hoi50028#NaN.
   Google Scholar
• Czernichow S, Bertrais S, Blacher J, et al. Metabolic syndrome in relation to structure and function of large arteries: a predominant effect of blood pressure. A report from the SU.VI.MAX. Vascular Study. Am J Hypertens. 2005;18:1154–1160.
   PubMed Web of Science ®Google Scholar
• Dabelea D, Talton JW, D'Agostino R, et al. Cardiovascular risk factors are associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care. 2013;36:3938–3943.
   PubMed Web of Science ®Google Scholar
• Weng C, Yuan H, Tang X, et al. Age- and gender dependent association between components of metabolic syndrome and subclinical arterial stiffness in a Chinese population. Int J Med Sci. 2012;9:730–737.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, O'Rourke M, Nichols WW. McDonald’s Blood Flow in Arteries, sixth edition: theoretical, experimental and clinical principles. Florida (FL): CRC Press; 2011.
   Google Scholar
• Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–2605.
   PubMed Web of Science ®Google Scholar
• O’Rourke MF, Staessen JA, Vlachopoulos C, et al. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens. 2002;15:426–444.
   PubMed Web of Science ®Google Scholar
• Lowry D, Saeed M, Narendran P, et al. A review of distribution of atherosclerosis in the lower limb arteries of patients with diabetes mellitus and peripheral vascular disease. Vasc Endovasc Surg. 2018;52:535–542.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119–1131.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol Levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557–1565.
   PubMed Web of Science ®Google Scholar
• Lacolley P, Regnault V, Segers P, et al. Vascular smooth muscle cells and arterial stiffening: relevance in development, aging, and disease. Physiol Rev. 2017;97:1555–1617.
   PubMed Web of Science ®Google Scholar
• Kutkiene S, Petrulioniene Z, Laucevicius A, et al. Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population. Lipids Health Dis. 2018;17:208.
   PubMed Web of Science ®Google Scholar
• Valensi P, Avignon A, Sultan A, et al. Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2016;15:104.
   PubMed Web of Science ®Google Scholar
• Boizel R, Benhamou PY, Lardy B, et al. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care. 2000;23:1679–1685.
   PubMed Web of Science ®Google Scholar
• Hirayama S, Miida T. Small dense LDL: an emerging risk factor for cardiovascular disease. Clin Chim Acta. 2012;414:215–224.
   PubMed Web of Science ®Google Scholar
• Moin DS, Rohatgi A. Clinical applications of advanced lipoprotein testing in diabetes mellitus. Clin Lipidol. 2011;6:371–387.
   PubMed Web of Science ®Google Scholar
• Cure MC, Tufekci A, Cure E, et al. Low-density lipoprotein subfraction, carotid artery intima-media thickness, nitric oxide, and tumor necrosis factor alpha are associated with newly diagnosed ischemic stroke. Ann Indian Acad Neurol. 2013;16:498–503.
   PubMed Web of Science ®Google Scholar
• Lupattelli G, Lombardini R, Schillaci G, et al. Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles. Am Heart J. 2000;140:521–526.
   PubMed Web of Science ®Google Scholar
• Superko HR. Beyond LDL cholesterol reduction. Circulation. 1996;94:2351–2354.
   PubMed Web of Science ®Google Scholar
• Lamarche B, Tchernof A, Moorjani S, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation. 1997;95:69–75.
   PubMed Web of Science ®Google Scholar
• Dobiásová M. AIP–atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr Lek. 2006;52:64–71.
   PubMedGoogle Scholar
• Choudhary MK, Eräranta A, Tikkakoski AJ, et al. Effect of present versus previous smoking on non-invasive haemodynamics. Sci Rep. 2018;8:13643.
   PubMed Web of Science ®Google Scholar